Pricing Log in Create free account
Saturday 17 October 2026 Export MCK’s income statement to Excel — free account

McKesson Corporation

MCK Healthcare Medical Distribution

McKesson Corporation’s revenue for fiscal 2026 (year ended March 2026) was $403.4 billion, up 12.4% from fiscal 2025. In the quarter to June 2026, revenue grew 7.72%, EPS fell 17.7%, free cash flow grew 66.4% and total debt rose 10.5%, each against the same quarter a year earlier. Member of the S&P 500; dividend growth for twenty-five consecutive years, revenue growth for ten.

1,006.92 8.28 +0.83%
Market cap
$116.4B
P/E
26.8×
Fwd P/E
18.3×
Dividend yield
0.34%
F-score
7/9
Altman Z
6.15
Beneish M
−2.34
Dividend safety
86/100
Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios Filings 10-Q 10-K

McKesson Corporation (MCK) EV/Sales

Alert me on EV/Sales

As of 16 October 2026, McKesson Corporation (MCK) trades at a EV/Sales of 0.3×. Over the past ten years it has ranged from 0.1× (April 2020) to 0.3× (March 2015); the current reading is higher than 95% of that period. That is below the Medical Distribution industry median of 0.6× and below the Healthcare sector median of 3.4×.

EV/Sales, daily

Embed this chart

Annual newest first

Period EV/Sales Change
FY2026 0.3× 11.72%
FY2025 0.3× (0.08%)
FY2024 0.3× 21.89%
FY2023 0.2× (1.93%)
FY2022 0.2× 25.98%
FY2021 0.2× 40.48%
FY2020 0.1× (7.75%)
FY2019 0.1× (20.78%)
FY2018 0.2× (15.20%)
FY2017 0.2× (7.92%)

Quarterly newest first

Period EV/Sales Change
Jun 2026 0.2× (14.96%)
Mar 2026 0.3× 3.01%
Dec 2025 0.3× 2.00%
Sep 2025 0.3× (0.37%)
42 more quarters

Against its own ten years

Low 0.1× High 0.3×
Ten-year median 0.2×
Current reading's percentile 99

EV/Sales against peers

Company EV/Sales
HKPD Cellyan Biotechnology Co., Ltd compare n/m
COR Cencora, Inc. compare 0.2×
CAH Cardinal Health, Inc. compare 0.3×
MCK McKesson Corporation 0.3×
COSM Cosmos Health Inc. compare 0.4×
ACH Accendra Health, Inc. compare 0.9×
HSIC Henry Schein, Inc. compare 0.9×
AHG Akso Health Group Sponsored ADR compare 1.8×
FOCL FocalTherics compare 2.1×
Medical Distribution industry median 0.6×
Healthcare sector median 3.4×
Market median 2.1×

What EV/Sales is

EV/Sales tells an investor how the value of a whole company, counting its debt and cash, compares with the sales it brings in.

((Stock Price × Shares (Basic, Weighted) (latest quarter)) + (Long Term Debt (Total) (latest quarter) + Current Part of Debt (latest quarter)) − Cash & Short Term Investments (latest quarter)) ÷ Revenue (TTM)

The full definition of EV/Sales →

More on MCK